BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yokoyama K, Hori M, Yoshida A. Anti-myelin oligodendrocyte glycoprotein antibody neuritis optica following anti-NMDA receptor encephalitis. Pediatrics International 2016;58:953-4. [DOI: 10.1111/ped.13053] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Berek K, Grams A, Uprimny C, Prieschl M, Ramberger M, Unterberger I, Deisenhammer F, Reindl M, Hegen H. Anti-NMDA receptor encephalitis and MOG-associated demyelination – a case report with long-term follow-up and a systematic review. BMC Neurol 2022;22:434. [DOI: 10.1186/s12883-022-02974-x] [Reference Citation Analysis]
2 Molazadeh N, Bose G, Lotan I, Levy M. Autoimmune diseases and cancers overlapping with myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): A systematic review. Mult Scler J Exp Transl Clin 2022;8:20552173221128170. [PMID: 36311694 DOI: 10.1177/20552173221128170] [Reference Citation Analysis]
3 Zhang S, Yang Y, Liu W, Li Z, Li J, Zhou D. Clinical Characteristics of Anti-N-Methyl-d-Aspartate Receptor Encephalitis Overlapping with Demyelinating Diseases: A Review. Front Immunol 2022;13:857443. [DOI: 10.3389/fimmu.2022.857443] [Reference Citation Analysis]
4 Chan JS, Nurul-Ain M, Mohamad NF, Wan Hitam WH, Thavaratnam LK. Recurrent Optic Neuritis in Paediatric Anti-N-Methyl-D-Aspartate Receptor (Anti-NMDAR) Encephalitis: Case Report and Literature Review. Neuroophthalmology 2022;46:258-63. [PMID: 35859635 DOI: 10.1080/01658107.2021.2014892] [Reference Citation Analysis]
5 Ding J, Li X, Tian Z. Clinical Features of Coexisting Anti-NMDAR and MOG Antibody-Associated Encephalitis: A Systematic Review and Meta-Analysis. Front Neurol 2021;12:711376. [PMID: 34512521 DOI: 10.3389/fneur.2021.711376] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
6 Chen W, Li Q, Wang T, Fan L, Gao L, Huang Z, Lin Y, Xue Q, Liu G, Su Y, Zhang Y. Overlapping syndrome of anti-N-methyl-D-aspartate receptor encephalitis and anti-myelin oligodendrocyte glycoprotein inflammatory demyelinating diseases: A distinct clinical entity? Mult Scler Relat Disord 2021;52:103020. [PMID: 34034214 DOI: 10.1016/j.msard.2021.103020] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
7 Nan D, Zhang Y, Han J, Jin T. Clinical features and management of coexisting anti-N-methyl-D-aspartate receptor encephalitis and myelin oligodendrocyte glycoprotein antibody-associated encephalomyelitis: a case report and review of the literature. Neurol Sci 2021;42:847-55. [PMID: 33409829 DOI: 10.1007/s10072-020-04942-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
8 Taraschenko O, Zabad R. Overlapping demyelinating syndrome and anti-N-methyl-d-aspartate receptor encephalitis with seizures. Epilepsy Behav Rep 2019;12:100338. [PMID: 31737864 DOI: 10.1016/j.ebr.2019.100338] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
9 Fan S, Xu Y, Ren H, Guan H, Feng F, Gao X, Ding D, Fang F, Shan G, Guan T, Zhang Y, Dai Y, Yao M, Peng B, Zhu Y, Cui L. Comparison of myelin oligodendrocyte glycoprotein (MOG)-antibody disease and AQP4-IgG-positive neuromyelitis optica spectrum disorder (NMOSD) when they co-exist with anti-NMDA (N-methyl-D-aspartate) receptor encephalitis. Mult Scler Relat Disord 2018;20:144-52. [PMID: 29414288 DOI: 10.1016/j.msard.2018.01.007] [Cited by in Crossref: 62] [Cited by in F6Publishing: 52] [Article Influence: 12.4] [Reference Citation Analysis]